Inhixa has “clinically proven efficacy”, the manufacturer claimed, and can also be used for venous thromboembolism prophylaxis and the treatment of unstable angina, among other conditions.

It comes in pre-filled syringes, with five strengths ranging from 2,000 IU (20mg) in 0.2ml solution, to 10,000 IU (100mg) in 1.0ml solution.

Each strength comes in a different colour and includes a needle guard.

Intrapharm’s chairman and CEO Kevin James said the company is “committed to providing a continuity of supply in [a] marketplace that has seen recent volatility and product shortages”.

The NHS price for a 10-syringe pack of Inhixa is: £16.69 for 20mg/0.2ml; £24.22 for 40mg/0.4ml; £31.41 for 60mg/0.6ml; £44.10 for 80mg/0.8ml; and £57.84 for 100mg/1ml.

To order, contact [email protected] or 01234 248632